The EpiPen litigation is a defining example of how state attorneys general take on powerful pharmaceutical companies to protect public interest. Dramatic price increases, alleged antitrust violations, and deceptive marketing practices have created a substantial financial burden for families and strained state healthcare budgets. By spearheading investigations and bringing lawsuits against the makers of EpiPen,… Read more
Category: Drug Pricing & PBM
Pharmacy Benefit Managers and Drug Pricing Reform
States are advancing enforcement and reform efforts to address opaque PBM practices and rising prescription costs.
Drug Pricing, Market Power, and the EpiPen Litigation
Supporting states in complex litigation involving pharmaceutical pricing, PBMs, and consumer protection violations.